Big pharma reaps big profits from single drugs

08/21/2013 | Quartz

Of the world's 11 largest pharmaceutical companies, six market a single drug that represented more than 10% of their total sales last year, according to journalist David Yanofsky. The company with the biggest portion of net sales in one drug was Abbott Laboratories with its rheumatoid arthritis treatment Humira, which accounted for more than 23% of the firm's sales, followed by Eli Lilly & Co., whose antidepressant Cymbalta made up more than 22% of net sales. The big exception: highly diversified Bayer, with no single product taking more than 5% of sales.

View Full Article in:

Quartz

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA